Société NeuroSense Therapeutics Ltd.
Actions
NRSN
IL0011809592
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,18 USD | +0,53% | -11,28% | +50,32% |
Métier
Nombre d'employés: 18
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Or Eisenberg
DFI | Director of Finance/CFO | 43 | 01/06/21 |
Hagit Binder
COO | Chief Operating Officer | - | - |
Shiran Zimri
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/20 |
Irit Shefer
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Ferenc Tracik
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/12/21 |
Chief Tech/Sci/R&D Officer | 63 | - | |
Diana Shtossel
LAW | General Counsel | - | 01/01/22 |
Corporate Officer/Principal | - | 01/03/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 56 | 21/12/21 | |
Chairman | 67 | 01/10/21 | |
Cary Claiborne
BRD | Director/Board Member | 64 | 01/12/21 |
Director/Board Member | 49 | 01/01/22 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 21/12/21 |
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 17 334 042 | 12 382 922 ( 71,44 %) | 0 | 71,44 % |
Coordonnées société
Neurosense Therapeutics Ltd.
11 HaMenofim Street Building B
46725, Herzliya
+
http://www.neurosense-tx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+50,32% | 20,45 M | |
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |
- Bourse
- Actions
- Action NRSN
- Société NeuroSense Therapeutics Ltd.